Evidence map›Paper›PMID 23229042›Full record

ArticleArchives of neurology2012

Differential diagnosis of Jakob-Creutzfeldt disease.

Ross W Paterson, Charles C Torres-Chae, Amy L Kuo, Tim Ando, Elizabeth A Nguyen, Katherine Wong, Stephen J DeArmond, Aissa Haman, Paul Garcia, David Y Johnson and 2 more

Open access · greenAbstract read
In one paragraph

Article in Archives of neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Diagnosis of Prion Diseases.Sub-cellular biochemistry · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Creutzfeldt-Jakob disease and other prion diseases.Nature reviews. Disease primers · 2024
    Review
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ross W Paterson
Charles C Torres-Chae
Amy L Kuo
Tim Ando
Elizabeth A Nguyen
Katherine Wong
Stephen J DeArmond
Aissa Haman
Paul Garcia
David Y Johnson
Bruce L Miller
Michael D Geschwind

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
UNDERSTANDING AND IMPROVING SMALL MOLECULE INHIBITORS OF PRION REPLICATIONP01AG021601 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRUSINER, STANLEY B · 2003 to 2013
$31.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
DEVELOPMENT OF ASSAY FOR CREUTZFELDT-JAKOB DISEASE-265002328-265002328N01NS002328 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI PRUSINER, STANLEY · 1985 to 2006
$5.9M
Predicting progression of human prion diseaseR01AG031189 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2008 to 2017
$5.7M
New Clinical Approaches to Creutzfeldt-Jakob DiseaseK23AG021989 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2003 to 2007
$602k
NCRR NIH HHS UL1 RR024131NIA NIH HHS K23 AG021989NIA NIH HHS K23AG021989NIA NIH HHS P01 AG021601NIA NIH HHS P01-AG021601NIA NIH HHS P50 AG023501NIA NIH HHS P50-AG023501NIA NIH HHS R01 AG031189NIA NIH HHS R01-AG031189NINDS NIH HHS N01-NS-0-2328
6 · The paper itself

Abstract

objectivesTo identify the misdiagnoses of patients with sporadic Jakob-Creutzfeldt disease (sCJD) during the course of their disease and determine which medical specialties saw patients with sCJD prior to the correct diagnosis being made and at what point in the disease course a correct diagnosis was made.

designRetrospective medical record review.

settingA specialty referral center of a tertiary academic medical center.

participantsOne hundred sixty-three serial patients over a 5.5-year period who ultimately had pathologically proven sCJD. The study used the subset of 97 patients for whom we had adequate medical records.

main outcome measuresOther diagnoses considered in the differential diagnosis and types of medical specialties assessing patients with sCJD.

resultsNinety-seven subjects' records were used in the final analysis. The most common disease categories of misdiagnosis were neurodegenerative, autoimmune/paraneoplastic, infectious, and toxic/metabolic disorders. The most common individual misdiagnoses were viral encephalitis, paraneoplastic disorder, depression, vertigo, Alzheimer disease, stroke, unspecified dementia, central nervous system vasculitis, peripheral neuropathy, and Hashimoto encephalopathy. The physicians who most commonly made these misdiagnoses were primary care physicians and neurologists; in the 18% of patients who were diagnosed correctly at their first assessment, the diagnosis was almost always by a neurologist. The mean time from onset to diagnosis was 7.9 months, an average of two-thirds of the way through their disease course.

conclusionsDiagnosis of sCJD is quite delayed. When evaluating patients with rapidly progressive dementia with suspected neurodegenerative, autoimmune, infectious, or toxic/metabolic etiology, sCJD should also be included in the differential diagnosis, and appropriate diagnostic tests, such as diffusion brain magnetic resonance imaging, should be considered. Primary care physicians and neurologists need improved training in sCJD diagnosis.

Indexed as

Diagnosis, DifferentialDiagnostic ErrorsAdultAgedAged, 80 and overCohort StudiesCreutzfeldt-Jakob SyndromeFemaleHumansMaleMiddle AgedOutcome Assessment, Health Care

Identifiers

PMID23229042
PMCPMC4401069
OpenAlexW2141392703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.